Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova Botanix is a private wellness and consumer health company that markets herbal supplements, topical products, vitamins, and CBD-related products under the Nova Botanix and CanaBD names. Available evidence indicates it operates primarily as a direct-to-consumer botanical and nutraceutical business rather than a drug-development biotech company. Its product catalog includes herbal extracts, resveratrol supplements, and topical preparations, and website text describes sourcing from certified organic farms in southern Oregon alongside a broader supplier network. The company also received a 2020 FDA warning letter related to CanaBD-branded CBD products that were promoted with COVID-19-related claims. Overall, Nova Botanix appears to be a small commercial-stage botanical wellness company with no identifiable clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova Botanix.